ARCHIVES

Congress Agrees On Jackson Lab Support, But does Not Add Money; Earmarks Hit NCI Budget

This article is from The Cancer Letter archive.

Vol. 15 No. 41 | October 27, 1989

Download PDF Visit The Full Archive

Related Articles

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Letter: ORI And Plotkin Should Release Report

June 23, 1995

In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin

October 1, 1976

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006